Announcements Trials
Browse Landscape

Phase

Phase 1 90Phase 1/2 55Phase 2 51Phase NA 13Phase 3 12Phase EARLY_PHASE1 4Phase 4 4

Status

Recruiting 2Unknown 1Active not recruiting 1

Sponsor Class

OTHER 62INDUSTRY 4

Study Type

Interventional 4

Sponsor

Cancer Type

CNS 4

Conditions

Multiple Myeloma 19Solid Tumor 18Breast Neoplasms 14Sarcoma 13Head and Neck Neoplasms 13Colorectal Neoplasms 13Neoplasms 12Lymphoma, B-Cell 12Squamous Cell Carcinoma of Head and Neck 11Pancreatic Neoplasms 11Leukemia, Myeloid, Acute 11Stomach Neoplasms 10Melanoma 10Lymphoma 9Carcinoma, Non-Small-Cell Lung 9Lung Neoplasms 8Prostatic Neoplasms 7Leukemia 7Burkitt Lymphoma 7Advanced Solid Tumors 7Ovarian Neoplasms 6Hematologic Neoplasms 6Glioblastoma 6Recurrence 5Osteosarcoma 5Lymphoma, Non-Hodgkin 5Carcinoma, Hepatocellular 5Triple Negative Breast Neoplasms 4Small Cell Lung Carcinoma 4Neoplasm Metastasis 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × INDUSTRY × Glioma × Clear all
NCT04943913 2025-12-11

Study of GC101 TIL in Brain Glioma (Soochow2)

Shanghai Juncell Therapeutics

Phase EARLY_PHASE1 Recruiting
50 enrolled
CNS

Glioma

NCT07077616 2025-12-08

TAMAVAQTM

Biogenea Pharmaceuticals Ltd.

Phase EARLY_PHASE1 Recruiting
29 enrolled
CNS

Glioma

NCT05023551 2025-09-16

Study of DSP-0390 in Patients With Recurrent High-Grade Glioma

Sumitomo Pharma America, Inc.

Phase EARLY_PHASE1 Active not recruiting
39 enrolled
CNS

Brain Neoplasms, Glioblastoma, Glioma

NCT05333588 2022-04-19

The Safety Study of Autologous TILs Therapy for Patients With Glioblastoma Multiforme.

Hebei Senlang Biotechnology Inc., Ltd.

Phase EARLY_PHASE1 Unknown
20 enrolled
CNS

Glioblastoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡